On 10 August 2024, the US Food and Drug Administration (FDA) announced it would not approve MDMA-assisted therapy as a treatment for moderate to severe post-traumatic stress disorder (PTSD), citing insufficient data to conclude the drug was safe and effective, despite promising results from a Phase 3 trial published in September 2023.

Authors

• Person: Not available Organization: BBC
  What Western medicine can learn from the ancient history of ... - BBC

Sources

• What Western medicine can learn from the ancient history of ... - BBC www.bbc.com BBC via serper

Referenced by nodes (3)

• MDMA concept
• PTSD concept
• United States Food and Drug Administration entity